Dow Jones Futures: Market Rally Making Bullish Transformation; ARM, Palantir Lead 7 Stocks Flexing [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
Investor's Business Daily Growth stocks have the best chance of success when in early-stage bases. These IBD 50 stocks show they are in the early innings. Zacks Pre-Markets in the Red to Start December Bloomberg (Bloomberg) -- For all the bullish milestones notched by November's big market surge, recent history offers Wall Street a lesson in caution. Most Read from BloombergBanking Escapees Make Billions From Private Credit BoomIsrael Says Hamas Violated Terms of Cease-Fire as Truce LapsesPutin Seizes Rights to St. Petersburg Airport From Foreign InvestorsSantos Expelled From Congress After Tumultuous Year of LiesBonds Up as Powell Pushback Lasts ‘A Few Seconds': Markets WrapTime and time again, specula Business Insider The S&P 500 climbed 9% and is trading close to its 2023 highs, powered higher by investors' belief the Fed is done raising interest rates. Barrons.com Robust gains in stocks such as Roku, Crispr Therapeutics, and Coinbase Global helped drive performa
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Is CRISPR Therapeutics Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- How Gene Editing Therapies Could Go Beyond Rare Diseases [Forbes]Forbes
- Ensoma Appoints Accomplished Company Builder and Product Developer, Jim Burns, Ph.D., as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $102.00 to $95.00. They now have an "outperform" rating on the stock.MarketBeat
CRSP
Earnings
- 5/9/24 - Beat
CRSP
Sec Filings
- 5/8/24 - Form 10-Q
- 5/8/24 - Form 8-K
- 4/17/24 - Form 4
- CRSP's page on the SEC website